Active ingredientUdenafilCat. No. P-U003-001CAS 268203-93-6Family · Pharmaceutical analytical standards
Udenafil
A phosphodiesterase 5 (PDE5) inhibitor, the same class as sildenafil, developed in South Korea and approved there in November 2005 for erectile dysfunction. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is also being studied in paediatric cardiology: in the large FUEL trial it was tested in adolescents who had undergone the Fontan procedure for a heart with only one working ventricle.
Go to the active ingredient →Active ingredientUdenafilCat. No. P-U003-001CAS 268203-93-6
Isotopically labelledUdenafil-d7Cat. No. P-U003-002CAS 1175992-76-3
ImpurityDespropoxy Ethoxy UdenafilCat. No. P-U003-003CAS 268204-07-5
ImpurityUdenafil Impurity 1Cat. No. P-U003-004
ImpurityUdenafil Impurity 2Cat. No. P-U003-005CAS 2562360-05-6
ImpurityUdenafil Impurity 3Cat. No. P-U003-007
ImpurityUdenafil Impurity 4Cat. No. P-U003-008CAS 936951-20-1
ImpurityUdenafil Impurity 5Cat. No. P-U003-009CAS 1810029-01-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.